Monostearin
lipidMonoglyceride lipid species reflecting lipid metabolism dysregulation in atherosclerotic lesion or post-intervention remodeling.
Pathway placement
Cascade stepLipid retention & oxidation
Confidencelow
RationaleLipid metabolite; in-stent restenosis-associated metabolic marker.
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma (EDTA to limit oxidation)
Collection tube
K2/K3-EDTA (lavender-top) · Serum separator (gold/red-top, SST)
Method / principle
LC-MS/MS lipidomics (targeted or shotgun)
Reagent / substrate
Deuterated lipid-class internal standards; MS/MS transitions
Platform
LC-MS/MS
Turnaround · availability
Research · Research-only
Literature evidence(1)
- Unbiased metabolomics screening for potential biomarkers in patients with In-stent restenosis post percutaneous coronary intervention.Scandinavian cardiovascular journal : SCJ · 2026 · PMID 41504866 · doi